Guidance And Execution UncertaintyInitial FY26 outlook that came in below expectations raises concern about the timing and visibility of revenue growth and the ability to deliver on projected margins.
Legacy Cost-structure RiskSignificant rightsizing remains after scaling for a prior migrant contract business, creating near-term cost pressure and execution risk while margins are reset.
Market Skepticism And Valuation PressureDiscounted analyst price targets and a wide valuation gap versus peers reflect investor skepticism about the durability and pace of the core payer-business ramp, which could weigh on the stock until growth proves sustainable.